Now that FAM3A is decreased in AAA, we questioned whether supplementation with FAM3A has the capacity to retain the well-differentiated VSMC status and reverse the VSMC reprogramming induced by the AAA microenvironment. This evidence concerns the gene FAM3A and triple-A syndrome.